Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.
about
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancerNon-coding landscapes of colorectal cancerCEBPA exerts a specific and biologically important proapoptotic role in pancreatic β cells through its downstream network targetsIdentification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysisCirculating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1.Major postoperative complications and survival for colon cancer elderly patientsPotential role of probiotics on colorectal cancer preventionCentenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems.miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cellsmiR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2.Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspectsPharmacological and dietary prevention for colorectal cancer.Social disparities, health risk behaviors, and cancer.Comparative transcriptomic analysis of the response to cold acclimation in Eucalyptus dunniiMicroRNAs in vitreus humor from patients with ocular diseasesmiR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.Expression Profiles of miRNA Subsets Distinguish Human Colorectal Carcinoma and Normal Colonic Mucosa.Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.Identification of serum microRNA profiles in colon cancerEffect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal cancer cells.Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery.miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.Comparison of the clinical outcomes of laparoscopic-assisted versus open surgery for colorectal cancerMiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications.ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5.A meta-analysis of short-term outcome of laparoscopic surgery versus conventional open surgery on colorectal carcinoma.JNK, p38, ERK, and SGK1 Inhibitors in Cancer.Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway.Buyang Huanwu Decoction (BYHWD) Enhances Angiogenic Effect of Mesenchymal Stem Cell by Upregulating VEGF Expression After Focal Cerebral Ischemia.CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.Evaluation of miR-720 prognostic significance in patients with colorectal cancer.Highly expressed placental miRNAs control key biological processes in human cancer cell lines.
P2860
Q26775610-A444C2C2-A9D5-4476-ACAF-D6EFC856AC1FQ26778014-DCD2445F-37B7-453A-987D-D5E5D27A4C34Q28654309-D43CC75E-A026-49C9-9875-1E144F34F902Q29416993-98741C06-7991-4ED9-8E98-F6BFAA9AE7A2Q30982356-87B7AD89-3BE5-4C54-B312-8EE4658B6B1AQ33732095-0F082592-B40C-4EE8-93E2-356298E69ADCQ33962495-17D695F3-DE6B-47A5-968F-C37AB0430D70Q34420579-EA8109F8-25E8-4D5C-B45C-89CE037923F2Q34485496-D3625B2C-26A5-41EB-B5B5-6565ACE3C912Q34485634-047FA9A1-452B-4359-B587-23768D55E000Q34485678-991B416A-9EAD-4AFF-B8F2-5B569DC3B5F7Q34566878-77172185-9077-47E2-B5DF-62C5AB0EBBB1Q34619395-BD3857F4-A926-45C1-B315-00E8EC942C6CQ35051317-DF76FCD3-9CEC-4EE3-9A77-124C75F60A21Q35051366-F2F766B6-177E-4D33-8FFF-51E43640E199Q35051412-E998F175-1B9A-4A04-A281-45870810EF4AQ35439677-7208436E-194E-4F8C-9E1E-B316573449FDQ36634670-688ACF17-DC19-4F35-8A20-3CAA7F86949CQ36759835-474354EF-6669-44C4-A08E-DDF08D015601Q36768940-ACE33973-218E-4080-9C66-EF4B6B43A484Q36782575-BCE7328B-D794-43E9-93F5-FA7B8E7A1B86Q36889636-77B1F0C1-C6B2-47DE-9BE4-9A56450524B3Q37288375-6D4F49BF-9B02-4215-8112-A8E75D4BA426Q37364383-18A5596D-244E-4701-AF7B-75096F19735CQ37601296-6C6EBCB8-D54F-4789-8863-9BE78D0B8444Q37652500-1ACD7F35-08F8-49A2-B0A9-000CCC0839B5Q38749995-2EB7A9A4-3CEA-4AFA-BF98-7B5853D58403Q38763316-F892CBF6-30BA-42DF-9E7A-81AA6F333D80Q38940586-34579F9A-2244-4FDD-A224-64B9D4874A32Q39147138-D42E0863-3689-472B-8D67-BD90CE95710BQ39394211-3F923042-B916-4478-A36C-9410B5EBC7B2Q41575072-EF8F0A49-5EDA-4CB6-9CCC-CD4B30763A60Q44924944-26486E9E-49B7-4D74-A985-DF50039B7FF9Q47196596-89ED5A18-5FEE-4E2E-AD9A-605393A38239Q47265464-26D722D7-38B0-4AD9-9895-D7F8C5FEDF7FQ47745693-7CAA5C7F-3C58-40DB-AE1E-04FC2EFD33D6Q48269293-53B92618-E84D-4706-A3EB-22BAC8476E5EQ50055209-E783CE8B-E05D-4A09-A37F-9B795EF2835DQ51046263-2378E729-4C43-4674-9455-E14A78653EA4Q55101214-00293CFE-221B-4763-80B6-D2EF89C7B7B7
P2860
Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@ast
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@en
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@nl
type
label
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@ast
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@en
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@nl
prefLabel
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@ast
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@en
Specific alterations of the mi ...... ment with MAPK/ERK inhibitors.
@nl
P2093
P2860
P50
P921
P1476
Specific alterations of the mi ...... tment with MAPK/ERK inhibitors
@en
P2093
Alessandra Majorana
Elisabetta Tendi
Enrico Vasquez
Francesco Basile
Loredana Salito
Luisa Statello
Manuela Santonocito
Mariangela Sammito
Michele Purrello
Rosario Angelica
P2860
P2888
P304
P356
10.1007/S00109-012-0918-8
P50
P577
2012-06-04T00:00:00Z
P5875
P6179
1044625841